Frank Karbe

Chief Financial Officer, Exelixis.

Companies

Cidara TherapeuticsChief financial officer Feb 26, 2025 to now¹
Phathom Pharmaceuticals, Inc.Board member Apr 26, 2022 to now²
Better Therapeutics, Inc.Chief executive officer Jul 31, 2023 to Dec 20, 2023³
Better Therapeutics, Inc.Board member Jul 7, 2022 to Dec 20, 2023⁴
Better Therapeutics, Inc.Officer Jul 7, 2022 to Apr 12, 2023⁴
Myovant Sciences Ltd.Principal Fin'l & Accounting Oct 26, 2016 to Jul 9, 2021⁵
CHINOOK THERAPEUTICS, INC.Board member Apr 19, 2019 to May 28, 2020⁶
Arbutus BiopharmaBoard member Dec 31, 2014 to Jun 23, 2017⁷
ExelixisChief financial officer Dec 12, 2006 to Feb 18, 2014⁸

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

May 19, 2026Granted 24,122 shares of Phathom Pharmaceuticals, Inc.⁹
Jan 7, 2026Returned to company 43,125 shares of Cidara Therapeutics¹⁰
Jan 7, 2026Returned to company 7,526 shares at $221.50 of Cidara Therapeutics¹⁰
Dec 10, 2025Shares withheld for tax 7,290 shares at $219.60 of Cidara Therapeutics¹²
Jun 3, 2025Granted 10,500 shares of Phathom Pharmaceuticals, Inc.¹³
Feb 24, 2025Granted 57,500 shares of Cidara Therapeutics¹⁴
Dec 13, 2024Bought 12,500 shares at $7.93 of Phathom Pharmaceuticals, Inc.¹⁵
May 29, 2024Granted 25,000 shares at $10.16 of Phathom Pharmaceuticals, Inc.¹⁶
May 23, 2024Granted 10,500 shares of Phathom Pharmaceuticals, Inc.¹⁷
Dec 18, 2023Granted 62,500 shares of Better Therapeutics, Inc.¹¹
Jul 27, 2023Bought 137,005 shares at $0.73 of Better Therapeutics, Inc.¹⁸
May 25, 2023Granted 9,000 shares of Phathom Pharmaceuticals, Inc.¹⁹
Apr 10, 2023Bought 242,424 shares at $0.83 of Better Therapeutics, Inc.²⁰
Sep 15, 2022Bought 50,000 shares at $2.09 of Better Therapeutics, Inc.²¹

The numbers on this page point here. Each one links to the record it came from.